Tuesday, May 24, 2022
Kashmir Bylines
No Result
View All Result
  • NewsLive
  • Cover Stories
  • Education
  • Politics
  • Conflict
  • Books
  • Opinion
  • World
  • Multimedia
    • Photo
    • Video
Kashmir Bylines
No Result
View All Result
Kashmir Bylines
No Result
View All Result

Leading COVID-19 vaccine trials halted as participant develops unexplained illness

News DeskbyNews Desk
September 9, 2020
in News, World
Leading COVID-19 vaccine trials halted as participant develops unexplained illness

The pharmaceutical company AstraZeneca on Tuesday said it has paused large, late-stage global trials of its experimental coronavirus vaccine because of a serious suspected adverse reaction in a study participant, reported New York Times.

It is not yet known whether the reaction was directly caused by the company’s vaccine or was coincidental.

The pause, which was first reported by STAT, will allow AstraZeneca, a British-Swedish company, to conduct a safety review and investigate whether the vaccine caused the illness. How long the hold will last is unclear.

Drug companies are racing to complete a coronavirus vaccine that could bring an end to a pandemic that has already claimed more than 8,90,000 lives globally.

AstraZeneca is one of three front-runner companies whose vaccines are in late-stage clinical trials. The company has said it hoped to have a vaccine ready before the end of the year. If the cause of the reaction turns out to be related to the vaccine, those efforts could be derailed.

In a statement, AstraZeneca described the trial’s halt, which was instituted voluntarily, as a “routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials.”

The company said that in large trials like the ones it is overseeing, participants do sometimes become sick by chance “but must be independently reviewed to check this carefully.”

The company said it was “working to expedite the review of the single event to minimize any potential impact on the trial timeline,” and reaffirmed its commitment “to the safety of our participants and the highest standards of conduct in our trials.”

A person familiar with the situation, who spoke on the condition of anonymity, said that the participant who experienced the suspected adverse reaction had been enrolled in a Phase 2/3 trial based in the United Kingdom. The individual also said that a volunteer in the UK trial had received a diagnosis of transverse myelitis, an inflammatory syndrome that affects the spinal cord and is often sparked by viral infections. However, the timing of this diagnosis, and whether it was directly linked to AstraZeneca’s vaccine, is still unknown.

AstraZeneca declined to comment on the location of the participant and did not confirm the diagnosis of transverse myelitis. “The event is being investigated by an independent committee, and it is too early to conclude the specific diagnosis,” the company said.

In a paper published in The Lancet in July, researchers behind AstraZeneca’s formulation reported that the majority of participants in the vaccine’s Phase 1/2 had experienced some mild or moderate side effects, including muscle aches and chills. None of the reactions, however, were considered severe or life-threatening, and resolved quickly. The vaccine was deemed safe enough to proceed to further testing.

AstraZeneca’s vaccine is in Phase 2/3 trials in England and India, and in Phase 3 trials in Brazil, South Africa and more than 60 sites in the United States.

Phase 3 trials evaluate whether vaccine candidates protect people from infection or severe disease compared to a placebo.

ADVERTISEMENT
ADVERTISEMENT
Donate
Join @KashmirBylines on Telegram

News Desk

News Desk

Kashmir Bylines is a news website. We bring to you news and views about politics, history, literature, education and culture.

RelatedPosts

Afghan experience proves the need for boots-on-ground policy: Army tells foreign envoys
News

Civilian killings in J&K to be probed by NIA

byNews Desk
October 19, 2021
0

...

Read more
News

22 PSA detainees from Kashmir shifted to Agra Jail

byNews Desk
October 19, 2021
0

...

Read more
IGP attends Kashmir University’s annual festival Sonzal as chief guest
News

Viral order about non-local labourers fake: IGP Kashmir

byNews Desk
October 17, 2021
0

...

Read more
Fire Shot
News

Two non-locals shot dead, one injured in Kulgam

byNews Desk
October 17, 2021
0

...

Read more
New retirement rules: Axe falls on JKBOSE orderly at the hands of chairperson serving on two-year extension
News

Syed Ali Geelani’s grandson, Doda teacher terminated from gov’t services

byNews Desk
October 16, 2021
0

...

Read more

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • About Us
  • Contact Us
  • Privacy Policy

© Kashmir Bylines 2020-2021. All rights reserved.

No Result
View All Result
  • News
  • Cover Stories
  • Education
  • Politics
  • Conflict
  • Books
  • Opinion
  • World
  • Multimedia
    • Photo
    • Video

© Kashmir Bylines 2020-2021. All rights reserved.

Share

Blogger
Delicious
Digg
Email
Facebook
Facebook messenger
Google
Hacker News
Line
LinkedIn
Mix
Odnoklassniki
PDF
Pinterest
Pocket
Print
Reddit
Renren
Short link
SMS
Skype
Telegram
Tumblr
Twitter
VKontakte
wechat
Weibo
WhatsApp
Xing
Yahoo! Mail
Powered by WP Socializer

Copy short link

Copy link
Powered by WP Socializer